查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2096454

眼科器材：市場洞察、競爭格局及市場預測 - 2034 年

Ophthalmic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

眼科器材市場概述

概述：

  • 2025年眼科器械市場規模估計為345億美元，預計2034年將達到548億美元。這一成長是由白內障、青光眼和視網膜疾病在全球範圍內的患病率上升、近視患病率加速成長、人口老齡化以及眼科醫療解決方案（包括手術、診斷和鏡片）的持續技術進步所推動的。
  • 全球眼科設備市場預計在 2026 年至 2034 年的預測期內將以 5.3% 的複合年成長率成長。
  • 按產品類型分類，預計到 2025 年，鏡片細分市場將佔 41% 的佔有率，從而推動眼科設備市場的發展。
  • 按應用領域分類，預計到 2025 年，白內障領域將佔市場佔有率的 38%，從而推動眼科設備市場的發展。
  • 按最終用戶分類，預計醫院領域將引領眼科設備市場，到 2025 年將佔市場佔有率的 46%。
  • 預計到 2025 年，北美將以 40% 的銷售額引領全球眼科設備市場，在全球區域市場佔有率中佔最高地位。

眼科器械包括用於診斷、監測和治療眼部及視覺系統疾病的專用醫療器材和植入。隨著白內障、青光眼、視網膜病變、老齡化黃斑部病變和屈光不正等眼科疾病在全球老齡化人口和螢幕使用時間較長的人群中發病率不斷上升，醫院、專科眼科診所和門診手術中心正利用不斷擴充的手術器械、診斷和監測系統以及矯正鏡片等工具，提供精準且微創的眼科護理。手術器械包括用於白內障摘除的白內障超音波乳化器、用於術中保護眼內組織的超音波物質、青光眼引流裝置、用於視網膜手術的玻璃體切除系統，以及用於屈光矯正和視網膜治療的準分子雷射和光凝固雷射。光學同調斷層掃描（OCT）系統、眼科超音波系統、眼底攝影機、裂隙燈和角膜地圖儀系統等診斷和監測設備能夠實現眼科疾病的早期檢測和後續觀察。由於全球對視力矯正的巨大需求，包括人工水晶體、軟式隱形眼鏡、硬式高透氧隱形眼鏡和眼鏡鏡片在內的各種鏡片仍然是最大的收入來源。在疾病負擔加重、人口老化、全球近視率上升以及飛秒雷射和準分子雷射平台和高階鏡片技術不斷創新的推動下，眼科設備已成為支撐現代眼科醫療的重要基礎設施。

眼科器械市場的主要市場促進因素

  • 隨著白內障、青光眼和視網膜疾病在全球的發病率不斷上升，手術數量也在增加。根據世界衛生組織（WHO）統計，全球約有 1.53 億人患有某種形式的視力障礙。
  • 近視在全球加速蔓延，推動了對矯正和穩定近視鏡鏡片的需求。世界衛生組織和布萊恩霍爾頓視覺研究所預測，到 2050 年，全球 50% 的人口將患有近視。
  • 隨著世界人口老化，白內障手術的數量不斷增加，促使對高階人工水晶體和超音波乳化（超音波白內障手術）平台的需求不斷成長。
  • 光學同調斷層掃描(OCT)、人工智慧輔助診斷篩檢以及飛秒雷射和準分子雷射平台等技術的不斷進步，正在提高檢測和手術的準確性。
  • 隨著微創眼科手術的普及，對先進的超音波乳化系統、青光眼引流裝置和小切口玻璃體切除系統的需求也日益成長。
  • 報銷體系的擴大以及白內障和屈光矯正手術向門診手術中心和專科診所的轉移，增加了人們獲得先進眼科設備的機會。
  • 積極的併購活動、投資和策略聯盟，例如愛爾康計劃收購 STAR Surgical Company 和 BVI Medical資金籌措10 億美元資金，正在擴大整個價值鏈的競爭力。

推動眼科設備市場成長的因素

市場促進因素

白內障、青光眼和視網膜疾病的全球發生率不斷上升。

眼科器械市場最根本的驅動力是全球眼科疾病負擔的沉重。白內障、青光眼、糖尿病視網膜病變和老齡化黃斑部病變是全球可預防性視力障礙和失明的主要原因，世界衛生組織（WHO）估計，全球約有1.53億人患有某種形式的視力障礙。隨著人口老化和糖尿病相關眼部併發症負擔的加重，這些疾病的盛行率不斷上升，對影像診斷、手術和矯正鏡片的需求也不斷成長。醫院和專科眼科診所正在加大對超音波儀、光學同調斷層掃描（OCT）設備和玻璃體切除系統的投資，以滿足日益成長的患者需求，這將為2034年之前眼科器械的強勁且持續的需求奠定基礎。

近視在全球範圍內的迅速蔓延

近視是視力矯正市場成長要素。世界衛生組織 (WHO) 和布萊恩霍爾頓視覺研究所預測，到 2050 年，全球約有一半人口將患有近視，其中約十分之一為高度近視。這將加速對用於視力矯正和近視控制的眼鏡和隱形眼鏡的需求。值得關注的例子包括：依視路 (Essilor) 的 Stellest 近視控制鏡片於 2025 年 9 月獲得美國食品藥物管理局(FDA) 的批准，該鏡片基於臨床數據，顯示其能顯著減緩近視鏡在兒童中近視鏡光學 (CooperVision) 擴大了其 MiSight 1-day 近視鏡在兒童的應用範圍。隨著都市化進程的加速以及兒童近視在螢幕使用人群中的盛行率上升，對診斷性角膜地圖儀和矯正鏡片技術的需求持續成長。

市場限制因素

儘管眼科器械市場發展勢頭強勁，但仍面臨諸多限制因素。包括高階飛秒雷射系統和光學同調斷層掃描（OCT）設備在內的先進診斷和手術平台高成本，限制了價格敏感市場和新興市場小規模診所和醫療機構的採用。高階人工水晶體、先進診斷影像和部分微創手術的保險報銷在不同地區仍存在差異，限制了器械的更新換代。全球訓練有素的眼科醫生和眼科外科醫生短缺，尤其是在農村和低收入地區，限制了手術器械的普及速度。人工水晶體和青光眼引流裝置等植入式醫療設備嚴格的法規核准流程延長了研發週期，並增加了合規成本。醫療設備召回和上市後監測要求也進一步加重了營運負擔。日益激烈的價格競爭，尤其是在標準人工水晶體和軟式隱形眼鏡等商品化產品領域，正在擠壓老牌製造商的利潤空間。在非洲、拉丁美洲和南亞的部分地區，儘管存在持續高發的疾病負擔、不斷上升的近視率和技術進步等根本因素，但眼科醫療保健基礎設施和診斷篩檢的匱乏仍然限制了市場滲透率。

區域說明

北美洲

到2025年，北美將佔全球眼科器械市場收入的40%。美國憑藉其強大的醫療保健基礎設施、清晰的保險報銷體系、龐大的白內障手術量以及主要製造商的集中佈局，在市場中佔主導地位；同時，高階鏡片和微創手術平台的持續創新進一步鞏固了其主導地位。

歐洲

歐洲是一個規模龐大且高度發展的區域市場，擁有完善的保險報銷體系、強大的眼科醫療設備製造商基礎（包括Ziemer眼科系統公司和佳能醫療系統歐洲公司），以及日益普及的先進診斷影像技術。依視路陸遜梯卡計劃收購Optegra眼科醫院網路（該網路覆蓋英國、捷克、波蘭、斯洛伐克和荷蘭），這表明該地區在診斷、手術和視力保健方面的融合程度正在不斷提高。

亞太地區

亞太地區是成長最快的地區，這主要受人口老化大規模、白內障手術量增加以及中國、日本、印度和韓國兒童近視快速蔓延等因素所驅動。醫院基礎設施的擴建、政府主導的篩檢計畫以及近視控制鏡片技術的日益普及，都在加速該地區對醫療設備的需求。

世界其他地區

涵蓋拉丁美洲、中東和非洲的「偏遠地區」代表著新的成長前沿。眼科醫療基礎設施的不斷改善、人們對可預防性失明的認知不斷提高，以及各國政府和非政府組織開展的篩檢舉措日益增多，正逐步提升該地區獲得眼科診斷和手術醫療設備的機會。同時，國際夥伴關係和醫療旅遊也為該地區醫療體系的持續發展提供了支持。

眼科器材市場近期發展趨勢

2026年，愛爾康公司宣布2026年第一季營收為27億美元，以報告數據計算成長10%。這一成長主要得益於其「Unity」和「Tryptyr」產品的上市。策略意義：鞏固愛爾康在外科和眼科醫療設備領域的領先地位。

2026年，博士倫公司推出了PreserVision AREDS3，這是一款改良配方，旨在為老齡化黃斑部病變提供營養支援。策略意義：這擴展了博士倫公司的視力保健產品系列，使其能夠更好地管理視網膜疾病。

2025年8月，愛爾康公司（Alcon Inc.）簽署最終合併協議，收購STAR Surgical公司，從而豐富其用於矯正中重度近視的EVO植入式膠原蛋白晶體產品組合。戰略意義：此次收購擴大了愛爾康公司的高階屈光體產品組合，並增強了其近視矯正產品的供應能力。

常見問題：

問題1：眼科器械市場的成長率是多少？

預計從 2026 年到 2034 年的預測期內，眼科設備市場將以 5.3% 的複合年成長率成長。

Q2. 眼科器材市場的市場規模有多大？

2025年眼科器械市場規模估計為345億美元，預計2034年將達到548億美元。

Q3. 哪個地區正在推動眼科器材市場的發展？

預計到2025年，北美將引領眼科器材市場，佔全球銷售額的40%，這主導其先進的醫療基礎設施、有利的保險報銷系統、大量的白內障手術以及主要醫療設備製造商的集中佈局。亞太地區預計將成為預測期內成長最快的地區。

第四季：眼科器械市場的主要促進因素是什麼？

主要促成因素包括白內障、青光眼和視網膜疾病在全球範圍內的日益普遍。根據世界衛生組織估計，約有1.53億人視力受損。此外，近視的全球蔓延速度正在加快，預計到2050年，全球將有50%的人口患有近視。另外，人口老化促使白內障手術數量增加，以及影像技術和微創手術的持續進步，也是造成視力下降的重要因素。

Q5. 眼科器材市場的主要參與者有哪些？

主要公司包括強生服務公司、百特公司、佳能醫療系統歐洲有限公司、庫博光學公司、愛爾康公司、博士倫公司、歐姆龍公司、Ziemer眼科系統股份公司、依視路儀器美國有限公司和科南醫療美國公司。

目錄

第1章：眼科器械市場報告簡介

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章：眼科器械市場摘要整理

  • 市場概覽

第3章：眼科器材市場關鍵因素分析

  • 眼科器材市場：市場促進因素
    • 白內障、青光眼和視網膜疾病的發生率增加。
    • 近視在全球的蔓延
    • 人口老化與白內障手術數量
    • 診斷影像技術的進步
  • 眼科器材市場的市場限制與挑戰
    • 先進醫療設備高成本且保險報銷不均
    • 熟練眼科醫師短缺
    • 監管複雜性和價格競爭
  • 眼科器材市場：市場機遇
    • 近視進展控制鏡片技術的擴展
    • 新興國家基礎建設的擴張

第4章 影響分析：人工智慧、地緣政治、貿易和經濟趨勢

第5章：監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章 眼科器材市場的波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的競爭

第7章：眼科器材市場評估

  • 依產品類型
    • 外科器械
    • 診斷和監測設備
    • 鏡片
    • 其他
  • 用途別
    • 青光眼
    • 白內障
    • 視網膜病變
    • 老齡化黃斑部病變
    • 近視
  • 最終用戶
    • 醫院
    • 專科診所
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第8章：眼科器材市場的競爭格局

  • 市場集中度與結構
  • 競爭定位與市場佔有率分析（加值服務）

第9章：眼科器材市場的新創企業資金籌措與投資趨勢

第10章：眼科器材市場：公司概況與產品概況

  • Johnson & Johnson Services, Inc.
    • 公司簡介
    • 公司簡介
    • 財務概覽
    • 服務組合
    • 策略舉措/熵
  • Baxter
    • 產品系列
  • CANON MEDICAL SYSTEMS EUROPE BV
  • CooperVision, Inc.
  • Alcon Inc.
  • Bausch & Lomb, Inc.
  • OMRON Corporation
  • Ziemer Ophthalmic Systems AG
  • Essilor Instruments USA Ltd.
  • Konan Medical USA, Inc.

第11章：KOL的觀點

第12章：專案式教學方法

第13章：關於 DelveInsight

第14章 免責聲明與聯絡方式

Product Code: DIMDCL0464

Ophthalmic Devices Market Summary

Overview:

  • The ophthalmic devices market is estimated at USD 34.50 billion in 2025 and is projected to reach USD 54.80 billion by 2034. Growth is anchored in the rising global prevalence of cataract, glaucoma, and retinal disorders, the accelerating myopia epidemic, an aging population, and continuous technological advancement in surgical, diagnostic, and lens-based eye-care solutions.
  • The global Ophthalmic Devices market is growing at a CAGR of 5.3% during the forecast period from 2026 to 2034.
  • By product type, the lenses segment dominated the ophthalmic devices market with a 41% share in 2025.
  • By application, the cataract segment dominated the ophthalmic devices market with a 38% share in 2025.
  • By end-user, the hospitals segment dominated the ophthalmic devices market with a 46% share in 2025.
  • North America dominated the global ophthalmic devices market revenue with a 40% share in 2025, representing the highest regional market share globally.

Ophthalmic devices encompass the specialized medical instruments and implants used to diagnose, monitor, and treat disorders of the eye and visual system. Because ocular conditions such as cataract, glaucoma, retinopathies, age-related macular degeneration, and refractive error affect a growing share of the aging and screen-exposed global population, hospitals, specialty eye clinics, and ambulatory surgical centers rely on an expanding toolkit of surgical devices, diagnostic and monitoring systems, and corrective lenses to deliver precise, minimally invasive eye care. Surgical devices span phacoemulsification systems for cataract removal, ophthalmic viscoelastic devices that protect intraocular tissue during surgery, glaucoma drainage devices, vitrectomy systems for retinal procedures, and excimer and photocoagulation lasers used in refractive and retinal treatment. Diagnostic and monitoring devices, including optical coherence tomography systems, ophthalmic ultrasound systems, fundus cameras, slit lamps, and corneal topography systems, enable early detection and longitudinal tracking of ocular disease. Lenses, comprising intraocular lenses, soft and rigid gas-permeable contact lenses, and spectacle lenses, remain the largest revenue contributor given the sheer scale of global vision-correction demand. Driven by rising disease burden, an aging population, the global rise in myopia, and continuous innovation in femtosecond and excimer laser platforms and premium lens technology, ophthalmic devices have become indispensable infrastructure underpinning modern eye-care delivery.

Ophthalmic Devices Market Key Growth Drivers

  • The rising global prevalence of cataract, glaucoma, and retinal disorders is expanding procedure volumes, with the World Health Organization estimating that approximately 153 million people worldwide are affected by some form of visual impairment.
  • The accelerating global myopia epidemic is driving demand for corrective and myopia-control lenses, with the WHO and Brien Holden Vision Institute projecting myopia to affect 50% of the global population by 2050.
  • An aging global population is expanding cataract surgical volumes and increasing demand for premium intraocular lenses and phacoemulsification platforms.
  • Continuous technological advancement in optical coherence tomography, AI-enabled diagnostic screening, and femtosecond and excimer laser platforms is improving detection accuracy and surgical precision.
  • Growing adoption of minimally invasive ophthalmic surgery is increasing demand for advanced phacoemulsification systems, glaucoma drainage devices, and small-incision vitrectomy systems.
  • Expanding reimbursement frameworks and the shift of cataract and refractive procedures toward ambulatory surgical centers and specialty clinics are broadening access to advanced ophthalmic devices.
  • Strong M&A, investment, and strategic partnership activity, including Alcon's planned acquisition of STAR Surgical Company and BVI Medical's USD 1 billion capital raise, is expanding competitive capacity across the value chain.

Key Companies in Ophthalmic Devices Market

The competitive landscape is led by the following active device manufacturers:

  • Johnson & Johnson Services, Inc.
  • Baxter
  • CANON MEDICAL SYSTEMS EUROPE B.V.
  • CooperVision, Inc.
  • Alcon Inc.
  • Bausch & Lomb, Inc.
  • OMRON Corporation
  • Ziemer Ophthalmic Systems AG
  • Essilor Instruments USA Ltd.
  • Konan Medical USA, Inc.

Factors Contributing to the Growth of the Ophthalmic Devices Market

Market Drivers

Rising Global Prevalence of Cataract, Glaucoma, and Retinal Disorders

The most fundamental driver of the Ophthalmic Devices market is the sheer scale of global eye-disease burden. Cataract, glaucoma, diabetic retinopathy, and age-related macular degeneration together account for the large majority of avoidable vision impairment and blindness worldwide, and the World Health Organization estimates that approximately 153 million people globally live with some form of visual impairment. As disease prevalence rises alongside population aging and the growing burden of diabetes-related eye complications, demand for diagnostic imaging, surgical intervention, and corrective lenses grows in parallel. Hospitals and specialty eye clinics increasingly invest in phacoemulsification systems, optical coherence tomography platforms, and vitrectomy systems to manage rising patient volumes, anchoring durable, recurring demand for ophthalmic devices through 2034.

Rapid Growth of the Global Myopia Epidemic

Myopia has become a defining growth driver for the vision-correction segment of the market. The World Health Organization and the Brien Holden Vision Institute project that myopia will affect roughly half of the global population by 2050, with high myopia affecting approximately one in ten people. This has accelerated demand for corrective and myopia-management spectacle and contact lenses, exemplified by the U.S. FDA's September 2025 authorization of Essilor Stellest myopia-control lenses following clinical data showing a substantial reduction in myopia progression, and by CooperVision's expanding MiSight 1-day pediatric myopia-control lens franchise. As childhood myopia prevalence climbs across urbanized, screen-intensive populations, demand for both diagnostic corneal topography and corrective lens technology continues to expand.

Market Restraints

Despite strong momentum, the Ophthalmic Devices market faces material constraints. The high cost of advanced diagnostic and surgical platforms, including premium femtosecond laser systems and optical coherence tomography devices, limits adoption among smaller clinics and providers in price-sensitive and emerging markets. Reimbursement for premium intraocular lenses, advanced diagnostic imaging, and select minimally invasive procedures remains uneven across geographies, constraining upgrade cycles. A global shortage of trained ophthalmologists and ophthalmic surgeons, particularly in rural and low-income regions, limits the pace at which surgical device capacity can be absorbed. Stringent regulatory approval pathways for implantable devices such as intraocular and glaucoma drainage devices lengthen development timelines and raise compliance costs, while device recalls and post-market surveillance requirements add further operational burden. Intensifying price competition, particularly in commoditized categories such as standard intraocular lenses and soft contact lenses, is pressuring margins for established manufacturers. Limited eye-care infrastructure and diagnostic screening access in parts of Africa, Latin America, and South Asia continue to constrain market penetration, even as the underlying drivers of disease burden, myopia growth, and technological advancement remain firmly intact.

Ophthalmic Devices Market Segment Analysis

The Ophthalmic Devices by Product Type (Surgical Devices [Phacoemulsification Devices, Ophthalmic Viscoelastic Devices, Glaucoma Drainage Devices, Vitrectomy Systems, Excimer Lasers, Photocoagulation Lasers, Others], Diagnostic and Monitoring Devices [Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras, Slit Lamps, Corneal Topography Systems, Others], Lenses [Intraocular Lenses, Contact Lenses (Soft Contact Lenses, Rigid Gas Permeable Contact Lenses), Spectacle Lenses, Others], Others), Application (Glaucoma, Cataract, Retinopathies, Age-Related Macular Degeneration, Myopia, Others), End-User (Hospitals, Specialty Clinics, Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).

By Product Type

Dominant Subsegment: Lenses. The lenses category is expected to dominate the market.

Dominant: Small Molecule ~ 51%

The lenses segment accounted for 41% of the ophthalmic devices market in 2025. Lenses lead the product-type segmentation because they address the largest and most universal category of eye-care need: vision correction. Intraocular lenses capture recurring demand tied to the very large and growing volume of cataract surgeries performed worldwide, while soft contact lenses and spectacle lenses serve a vast and expanding base of patients with refractive error and myopia. The accelerating global myopia epidemic, growing adoption of premium toric and multifocal intraocular lenses, and rising demand for daily-disposable and myopia-control contact lenses, illustrated by CooperVision's MiSight 1-day and EssilorLuxottica's Essilor Stellest, sustain the segment's scale. While diagnostic and monitoring devices are the fastest-growing product category, propelled by optical coherence tomography and AI-enabled screening, the sheer volume and recurrence of lens-based vision correction secure the lenses segment's leadership across the forecast period.

By Application

Dominant Subsegment: Cataract. The cataract category is expected to dominate the market.

Dominant: Cataract ~ 38%

The cataract segment accounted for 38% of the ophthalmic devices market in 2025. Cataract is the leading application because it remains the single largest cause of reversible blindness worldwide and generates the highest volume of ophthalmic surgical procedures. Rising life expectancy and an aging global population continue to expand the eligible patient pool, driving sustained demand for phacoemulsification devices, ophthalmic viscoelastic devices, and both standard and premium intraocular lenses. The high-frequency, well-reimbursed nature of cataract surgery, combined with growing patient demand for premium lens upgrades, secures large and dependable device demand. While myopia is the fastest-growing application given the accelerating global myopia epidemic among children and young adults, the scale, frequency, and clinical maturity of cataract surgery keep it the dominant application across the forecast period.

Ophthalmic Devices Market Region Analysis

Dominant Region: North America

Dominant: North America ~ 40% (Largest)

North America accounted for 40% of the global ophthalmic devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced healthcare infrastructure, high adoption of innovative surgical and diagnostic technology, favorable reimbursement frameworks for cataract and refractive procedures, and the concentrated presence of leading device manufacturers including Alcon, Johnson & Johnson Vision, Bausch & Lomb, and CooperVision. The United States drives the bulk of regional demand, supported by a large aging population, high cataract surgical volumes, and rapid adoption of premium intraocular lenses and advanced diagnostic imaging. Continued innovation, including Alcon's Voyager DSLT glaucoma laser and expanding ambulatory surgical center capacity, reinforces the region's leadership, while strong private and public reimbursement sustains device upgrade cycles across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the ophthalmic devices market. The region's elevated CAGR is driven by a large and rapidly aging population, rising cataract surgical volumes, an accelerating childhood myopia epidemic across China, Japan, South Korea, and India, and expanding healthcare infrastructure investment. China is scaling domestic ophthalmic device manufacturing and hospital capacity, Japan continues to adopt advanced diagnostic and myopia-control technologies, exemplified by CooperVision's 2025 MiSight approval, India benefits from expanding low-cost cataract surgical capacity and rising eye-health awareness, and South Korea and Australia are adopting premium diagnostic and surgical platforms. Government screening programs, rising disposable income, and growing medical tourism further accelerate device adoption, positioning Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 40% of the global Ophthalmic Devices market revenue in 2025. The United States dominates on the strength of its healthcare infrastructure, reimbursement clarity, high cataract surgical volumes, and concentration of leading manufacturers, while continued innovation in premium lenses and minimally invasive surgical platforms reinforces its leadership.

Europe

Europe is a large and advanced regional market, supported by well-established reimbursement systems, a strong base of ophthalmic device manufacturers including Ziemer Ophthalmic Systems and Canon Medical Systems Europe, and rising adoption of advanced diagnostic imaging. EssilorLuxottica's planned acquisition of the Optegra eye-hospital network across the United Kingdom, Czech Republic, Poland, Slovakia, and the Netherlands illustrates the region's growing integration of diagnostics, surgery, and vision care.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a large aging population, accelerating cataract surgical volumes, and a rapidly rising childhood myopia epidemic across China, Japan, India, and South Korea. Expanding hospital infrastructure, government screening initiatives, and growing adoption of myopia-control lens technology are accelerating regional device demand.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding eye-care infrastructure, rising awareness of preventable blindness, and growing government and non-governmental screening initiatives are gradually broadening access to diagnostic and surgical ophthalmic devices, while international partnerships and medical tourism support continued build-out of regional capacity.

Ophthalmic Devices Market Competitive Landscape

The Ophthalmic Devices market is classified as Moderately Fragmented. A group of large, diversified players with broad surgical, diagnostic, and lens portfolios, including Alcon, Johnson & Johnson Vision, Bausch & Lomb, and CooperVision, anchor the top tier through global manufacturing scale and reimbursement relationships, while specialized diagnostic and surgical-equipment providers such as Canon Medical Systems Europe, Ziemer Ophthalmic Systems, Konan Medical, OMRON, Essilor Instruments, and Baxter compete through technology depth, regional presence, and focused product innovation, sustaining active competition across surgical, diagnostic, and lens categories.

The competitive landscape can be evaluated across the following dimensions:

  • Market concentration: Moderately fragmented, with large diversified vision-care companies leading and a broad field of specialized surgical, diagnostic, and imaging device providers.
  • Leading players: Alcon, Johnson & Johnson Vision, Bausch & Lomb, and CooperVision anchor the top tier through global manufacturing scale and broad surgical and lens portfolios.
  • Geographic reach: Leaders operate global commercial networks spanning North America, Europe, and Asia-Pacific; Alcon reported first-quarter 2026 sales of USD 2.7 billion, underscoring the scale of leading players.
  • Product portfolio strength: Top players offer end-to-end portfolios spanning surgical devices, diagnostic and monitoring systems, and intraocular, contact, and spectacle lenses.
  • Technology and innovation access: Ownership of advanced surgical laser platforms, premium intraocular lens technology, and AI-enabled diagnostic imaging is a decisive competitive advantage.
  • Strategic partnerships: Tie-ups such as Ziemer's collaboration with CorneaGen on the GALILEI CTAK module and CooperVision's regulatory partnerships extend clinical reach.
  • M&A activity: Active consolidation, including Alcon's planned acquisition of STAR Surgical Company and EssilorLuxottica's planned acquisition of the Optegra eye-hospital network.
  • Manufacturing capabilities: Precision optics manufacturing, laser-system engineering, and lens-casting capacity at scale are key competitive moats.
  • Innovation focus: Myopia-control lens technology, AI-enabled diagnostic screening, minimally invasive surgical platforms, and premium intraocular lens design.

Ophthalmic Devices Market Recent Developmental Activities

In 2026, Alcon Inc. reported first-quarter 2026 sales of USD 2.7 billion, up 10% on a reported basis, with growth momentum from its Unity and Tryptyr product launches. Strategic significance: Reinforces Alcon's leadership position across surgical and vision-care device categories.

In 2026, Bausch & Lomb, Inc. introduced PreserVision AREDS3, an updated formulation supporting the nutritional management of age-related macular degeneration. Strategic significance: Extends Bausch & Lomb's vision-care portfolio addressing retinal disease management.

In August 2025, Alcon Inc. entered into a definitive merger agreement to acquire STAR Surgical Company, adding the EVO Implantable Collamer Lens portfolio for moderate-to-high myopia correction. Strategic significance: Expands Alcon's premium refractive lens portfolio and strengthens its myopia-correction offering.

Ophthalmic Devices Market Segmentation

Ophthalmic Devices Market by Product Type

  • Surgical Devices
  • Phacoemulsification Devices
  • Ophthalmic Viscoelastic Devices
  • Glaucoma Drainage Devices
  • Vitrectomy Systems
  • Excimer Lasers
  • Photocoagulation Lasers
  • Others
  • Diagnostic and Monitoring Devices
  • Optical Coherence Tomography Systems
  • Ophthalmic Ultrasound Systems
  • Fundus Cameras
  • Slit Lamps
  • Corneal Topography Systems
  • Others
  • Lenses
  • Intraocular Lenses
  • Contact Lenses

◦ Soft Contact Lenses

◦ Rigid Gas Permeable Contact Lenses

  • Spectacle Lenses
  • Others
  • Others

Ophthalmic Devices Market by Application

  • Glaucoma
  • Cataract
  • Retinopathies
  • Age-Related Macular Degeneration
  • Myopia
  • Others

Ophthalmic Devices Market by End-User

  • Hospitals
  • Specialty Clinics
  • Others

Ophthalmic Devices Market by Geography

  • North America Ophthalmic Devices Market
  • United States Ophthalmic Devices Market Size in USD million (2023-2034)
  • Canada Ophthalmic Devices Market Size in USD million (2023-2034)
  • Mexico Ophthalmic Devices Market Size in USD million (2023-2034)
  • Europe Ophthalmic Devices Market
  • Germany Ophthalmic Devices Market Size in USD million (2023-2034)
  • United Kingdom Ophthalmic Devices Market Size in USD million (2023-2034)
  • France Ophthalmic Devices Market Size in USD million (2023-2034)
  • Italy Ophthalmic Devices Market Size in USD million (2023-2034)
  • Spain Ophthalmic Devices Market Size in USD million (2023-2034)
  • Rest of Europe Ophthalmic Devices Market Size in USD million (2023-2034)
  • Asia-Pacific Ophthalmic Devices Market
  • China Ophthalmic Devices Market Size in USD million (2023-2034)
  • Japan Ophthalmic Devices Market Size in USD million (2023-2034)
  • India Ophthalmic Devices Market Size in USD million (2023-2034)
  • Australia Ophthalmic Devices Market Size in USD million (2023-2034)
  • South Korea Ophthalmic Devices Market Size in USD million (2023-2034)
  • Rest of Asia-Pacific Ophthalmic Devices Market Size in USD million (2023-2034)
  • Rest of the World (RoW) Ophthalmic Devices Market
  • Middle East Ophthalmic Devices Market Size in USD million (2023-2034)
  • Africa Ophthalmic Devices Market Size in USD million (2023-2034)
  • South America Ophthalmic Devices Market Size in USD million (2023-2034)

Key Takeaways from the Ophthalmic Devices Market Report Study

  • Market size analysis for the current ophthalmic devices market size (2025), and market forecast for 9 years (2026 to 2034).
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
  • Key companies dominating the global ophthalmic devices market.
  • Various opportunities available for competitors in the ophthalmic devices market space.
  • What are the top-performing segments in 2025? How will these segments perform in 2034?
  • Which are the top-performing regions and countries in the current ophthalmic devices market scenario?
  • Which are the regions and countries where companies should concentrate their opportunities for ophthalmic devices market growth in the future?

Target audience who can benefit from this Ophthalmic Devices market report study

  • Ophthalmic devices product providers
  • Research organizations and consulting companies
  • Ophthalmic devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in ophthalmic devices
  • Various end-users who want to know more about the ophthalmic devices market and the latest technological developments in the ophthalmic devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the ophthalmic devices market?

The ophthalmic devices market is projected to expand at a CAGR of 5.3% during the forecast period from 2026-2034.

Q2. What is the market size of the ophthalmic devices market?

The ophthalmic devices market is estimated at USD 34.50 billion in 2025 and is projected to reach USD 54.80 billion by 2034.

Q3. Which region dominates the ophthalmic devices market?

North America dominated the ophthalmic devices market with a 40% share of global revenue in 2025, supported by advanced healthcare infrastructure, favorable reimbursement, high cataract surgical volumes, and the concentrated presence of leading device manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the ophthalmic devices market?

The principal drivers are the rising global prevalence of cataract, glaucoma, and retinal disorders, with the WHO estimating roughly 153 million people affected by visual impairment; the accelerating global myopia epidemic, projected to affect 50% of the population by 2050; an aging population expanding cataract surgical volumes; and continuous technological advancement in diagnostic imaging and minimally invasive surgery.

Q5. Who are the major players in the ophthalmic devices market?

The major players include Johnson & Johnson Services, Inc., Baxter, CANON MEDICAL SYSTEMS EUROPE B.V., CooperVision, Inc., Alcon Inc., Bausch & Lomb, Inc., OMRON Corporation, Ziemer Ophthalmic Systems AG, Essilor Instruments USA Ltd., and Konan Medical USA, Inc., among others.

Table of Contents

1. Ophthalmic Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumptions

2. Ophthalmic Devices Market Executive Summary

  • 2.1 Market at a Glance

3. Ophthalmic Devices Market Key Factors Analysis

  • 3.1 Ophthalmic Devices Market Drivers
    • 3.1.1 Rising Prevalence of Cataract, Glaucoma, and Retinal Disorders
    • 3.1.2 Growth of the Global Myopia Epidemic
    • 3.1.3 Aging Population and Cataract Surgical Volumes
    • 3.1.4 Technological Advancements in Diagnostic Imaging
  • 3.2 Ophthalmic Devices Market Restraints and Challenges
    • 3.2.1 High Cost of Advanced Devices and Uneven Reimbursement
    • 3.2.2 Shortage of Trained Ophthalmologists
    • 3.2.3 Regulatory Complexity and Price Competition
  • 3.3 Ophthalmic Devices Market Opportunities
    • 3.3.1 Myopia-Control Lens Technology Expansion
    • 3.3.2 Emerging-Market Infrastructure Build-Out

4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments

5. Regulatory Analysis

  • 5.1 United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Ophthalmic Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Buyers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Ophthalmic Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Surgical Devices
      • 7.1.1.1 Phacoemulsification Devices
      • 7.1.1.2 Ophthalmic Viscoelastic Devices
      • 7.1.1.3 Glaucoma Drainage Devices
      • 7.1.1.4 Vitrectomy Systems
      • 7.1.1.5 Excimer Lasers
      • 7.1.1.6 Photocoagulation Lasers
      • 7.1.1.7 Others
    • 7.1.2 Diagnostic and Monitoring Devices
      • 7.1.2.1 Optical Coherence Tomography Systems
      • 7.1.2.2 Ophthalmic Ultrasound Systems
      • 7.1.2.3 Fundus Cameras
      • 7.1.2.4 Slit Lamps
      • 7.1.2.5 Corneal Topography Systems
      • 7.1.2.6 Others
    • 7.1.3 Lenses
      • 7.1.3.1 Intraocular Lenses
      • 7.1.3.2 Contact Lenses
      • 7.1.3.2.1 Soft Contact Lenses
      • 7.1.3.2.2 Rigid Gas Permeable Contact Lenses
      • 7.1.3.3 Spectacle Lenses
      • 7.1.3.4 Others
    • 7.1.4 Others
  • 7.2 By Application
    • 7.2.1 Glaucoma
    • 7.2.2 Cataract
    • 7.2.3 Retinopathies
    • 7.2.4 Age-Related Macular Degeneration
    • 7.2.5 Myopia
    • 7.2.6 Others
  • 7.3 By End-User
    • 7.3.1 Hospitals
    • 7.3.2 Specialty Clinics
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.1.2 Canada Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.1.3 Mexico Ophthalmic Devices Market Size in USD million (2023-2034)
    • 7.4.2 Europe
      • 7.4.2.1 Germany Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.2.2 United Kingdom Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.2.3 France Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.2.4 Italy Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.2.5 Spain Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.2.6 Rest of Europe Ophthalmic Devices Market Size in USD million (2023-2034)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.3.2 Japan Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.3.3 India Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.3.4 Australia Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.3.5 South Korea Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.3.6 Rest of Asia-Pacific Ophthalmic Devices Market Size in USD million (2023-2034)
    • 7.4.4 Rest of World
      • 7.4.4.1 Middle East Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.4.2 Africa Ophthalmic Devices Market Size in USD million (2023-2034)
      • 7.4.4.3 South America Ophthalmic Devices Market Size in USD million (2023-2034)

8. Ophthalmic Devices Market Competitive Landscape

  • 8.1 Market Concentration and Structure
  • 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)

9. Ophthalmic Devices Market Startup Funding and Investment Trends

10. Ophthalmic Devices Market Company and Product Profiles

  • 10.1 Johnson & Johnson Services, Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Service Portfolio
    • 10.1.5 Strategic Initiatives / Entropy
  • 10.2 Baxter
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Portfolio
    • 10.2.5 Strategic Initiatives / Entropy
  • 10.3 CANON MEDICAL SYSTEMS EUROPE B.V.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Portfolio
    • 10.3.5 Strategic Initiatives / Entropy
  • 10.4 CooperVision, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Portfolio
    • 10.4.5 Strategic Initiatives / Entropy
  • 10.5 Alcon Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Portfolio
    • 10.5.5 Strategic Initiatives / Entropy
  • 10.6 Bausch & Lomb, Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Portfolio
    • 10.6.5 Strategic Initiatives / Entropy
  • 10.7 OMRON Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Portfolio
    • 10.7.5 Strategic Initiatives / Entropy
  • 10.8 Ziemer Ophthalmic Systems AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Portfolio
    • 10.8.5 Strategic Initiatives / Entropy
  • 10.9 Essilor Instruments USA Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Portfolio
    • 10.9.5 Strategic Initiatives / Entropy
  • 10.10 Konan Medical USA, Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Portfolio
    • 10.10.5 Strategic Initiatives / Entropy

For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer and Contact Us

List of Tables

  • Table 1: Ophthalmic Devices Market in Global (2023-2034)
  • Table 2: Ophthalmic Devices Market in Global by Product Type (2023-2034)
  • Table 3: Ophthalmic Devices Market in Global by Application (2023-2034)
  • Table 4: Ophthalmic Devices Market in Global by End-Users (2023-2034)
  • Table 5: Ophthalmic Devices Market in Global by Geography (2023-2034)
  • Table 6: Ophthalmic Devices Market in North America (2023-2034)
  • Table 7: Ophthalmic Devices Market in the United States (2023-2034)
  • Table 8: Ophthalmic Devices Market in Canada (2023-2034)
  • Table 9: Ophthalmic Devices Market in Mexico (2023-2034)
  • Table 10: Ophthalmic Devices Market in Europe (2023-2034)
  • Table 11: Ophthalmic Devices Market in Germany (2023-2034)
  • Table 12: Ophthalmic Devices Market in United Kingdom (2023-2034)
  • Table 13: Ophthalmic Devices Market in France (2023-2034)
  • Table 14: Ophthalmic Devices Market in Italy (2023-2034)
  • Table 15: Ophthalmic Devices Market in Spain (2023-2034)
  • Table 16: Ophthalmic Devices Market in the Rest of Europe (2023-2034)
  • Table 17: Ophthalmic Devices Market in Asia-Pacific (2023-2034)
  • Table 18: Ophthalmic Devices Market in China (2023-2034)
  • Table 19: Ophthalmic Devices Market in Japan (2023-2034)
  • Table 20: Ophthalmic Devices Market in India (2023-2034)
  • Table 21: Ophthalmic Devices Market in Australia (2023-2034)
  • Table 22: Ophthalmic Devices Market in South Korea (2023-2034)
  • Table 23: Ophthalmic Devices Market in Rest of Asia-Pacific (2023-2034)
  • Table 24: Ophthalmic Devices Market in the Rest of the World (2023-2034)
  • Table 25: Ophthalmic Devices Market in the Middle East (2023-2034)
  • Table 26: Ophthalmic Devices Market in Africa (2023-2034)
  • Table 27: Ophthalmic Devices Market in South America (2023-2034)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding and Investment Trends

List of Figures

  • Figure 1: Ophthalmic Devices Market Drivers
  • Figure 2: Ophthalmic Devices Market Restraints
  • Figure 3: Ophthalmic Devices Market Opportunities
  • Figure 4: Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
  • Figure 5: Regulatory Analysis (US, EU, Japan, China)
  • Figure 6: Porter's Five Forces Analysis
  • Figure 7: Competitive Analysis
  • Figure 8: Ophthalmic Devices Market in Global (2023-2034)
  • Figure 9: Ophthalmic Devices Market in Global by Product Type (2023-2034)
  • Figure 10: Ophthalmic Devices Market in Global by Application (2023-2034)
  • Figure 11: Ophthalmic Devices Market in Global by End-Users (2023-2034)
  • Figure 12: Ophthalmic Devices Market in Global by Geography (2023-2034)
  • Figure 13: Ophthalmic Devices Market in North America (2023-2034)
  • Figure 14: Ophthalmic Devices Market in the United States (2023-2034)
  • Figure 15: Ophthalmic Devices Market in Canada (2023-2034)
  • Figure 16: Ophthalmic Devices Market in Mexico (2023-2034)
  • Figure 17: Ophthalmic Devices Market in Europe (2023-2034)
  • Figure 18: Ophthalmic Devices Market in Germany (2023-2034)
  • Figure 19: Ophthalmic Devices Market in United Kingdom (2023-2034)
  • Figure 20: Ophthalmic Devices Market in France (2023-2034)
  • Figure 21: Ophthalmic Devices Market in Italy (2023-2034)
  • Figure 22: Ophthalmic Devices Market in Spain (2023-2034)
  • Figure 23: Ophthalmic Devices Market in the Rest of Europe (2023-2034)
  • Figure 24: Ophthalmic Devices Market in Asia-Pacific (2023-2034)
  • Figure 25: Ophthalmic Devices Market in China (2023-2034)
  • Figure 26: Ophthalmic Devices Market in Japan (2023-2034)
  • Figure 27: Ophthalmic Devices Market in India (2023-2034)
  • Figure 28: Ophthalmic Devices Market in Australia (2023-2034)
  • Figure 29: Ophthalmic Devices Market in South Korea (2023-2034)
  • Figure 30: Ophthalmic Devices Market in Rest of Asia-Pacific (2023-2034)
  • Figure 31: Ophthalmic Devices Market in the Rest of the World (2023-2034)
  • Figure 32: Ophthalmic Devices Market in the Middle East (2023-2034)
  • Figure 33: Ophthalmic Devices Market in Africa (2023-2034)
  • Figure 34: Ophthalmic Devices Market in South America (2023-2034)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding and Investment Trends